Perioperative & Surgical Care

Postoperative atelectasis and pneumonia prevention

Clinical Overview and When to Suspect Postoperative Pulmonary Complications

— Diaphragmatic dysfunction from supine positioning and neuromuscular blockade

— Absorption atelectasis from high FiO₂

— Loss of functional residual capacity (FRC) by 15–20% under GA

— Impaired mucociliary clearance and cough (pain, opioids, splinting)

Step 3 management: Suspect PPC in any post-op patient on POD 1–5 with new fever, tachypnea, hypoxemia (SpO₂ <92%), or unexplained tachycardia. The initial bedside framework: assess airway/oxygenation, mobilize, incentive spirometry, then decide whether imaging and antibiotics are warranted.

Board pearl: Fever in the first 48 hours post-op is far more likely atelectasis or inflammatory response than pneumonia; fever appearing POD 3 or later with productive cough and infiltrate raises the suspicion for HAP. Don't reflexively start antibiotics for early postoperative fever — assess clinically first, because antibiotic overuse drives C. difficile and resistance, a Step 3 stewardship theme.

Definition spectrum: Postoperative pulmonary complications (PPCs) encompass atelectasis, hospital-acquired pneumonia (HAP), respiratory failure, bronchospasm, and pleural effusion — collectively the #2 cause of postoperative morbidity after surgical site infection and a leading driver of 30-day readmission and mortality.

Atelectasis is nearly universal after general anesthesia (affecting ~90% of patients on CT), driven by:

Postoperative pneumonia typically emerges days 2–5 post-op, often layered on persistent atelectasis. Defined by new infiltrate + ≥2 of: fever, leukocytosis/leukopenia, purulent secretions, hypoxemia, declining oxygenation.

Highest-risk surgeries: upper abdominal, thoracic, AAA repair, esophagectomy, emergency surgery, prolonged (>3 hr) cases.

Highest-risk patients: age >65, current smoker, COPD/asthma, OSA, CHF, frailty, albumin <3.5, functional dependence, ASA class ≥3.

Presentation Patterns and Key History

— Low-grade fever (often <38.5°C), mild tachypnea, mild hypoxemia

— Dry or minimally productive cough, decreased breath sounds at bases

— Often clinically silent — detected only by pulse oximetry trend or routine CXR

— Higher fever (>38.5°C), productive purulent sputum, pleuritic chest pain

— Worsening hypoxemia requiring escalating O₂, tachycardia, confusion (elderly)

— May present as failure to wean from ventilator (VAP variant)

— Surgery type and duration: upper abdominal/thoracic >> lower abdominal/peripheral

— Anesthesia type: general with intubation > regional/neuraxial

— Smoking status: active smoker within 8 weeks doubles PPC risk; cessation <4 weeks paradoxically may not reduce risk

— Baseline pulmonary disease: COPD, asthma control, recent exacerbations, home O₂

— OSA screening: STOP-BANG ≥3 — these patients are uniquely vulnerable to opioid-induced hypoventilation

— Functional status: inability to climb 1 flight of stairs predicts complications

— Nutritional status: preoperative albumin <3.0 g/dL is a strong independent predictor

— Aspiration risk: dysphagia, prior stroke, dementia, GERD, NG tube use

Key distinction: Fat embolism syndrome (24–72 hr after long-bone fracture/orthopedic surgery) mimics PPC with hypoxemia and tachypnea but adds petechiae, neurologic changes, and thrombocytopenia — a classic Step 3 differential trap. Pulmonary embolism presents with sudden hypoxemia and pleuritic pain without preceding productive cough or fever pattern; suspicion of PE warrants different workup entirely.

Board pearl: A post-op patient with delirium as the only sign may be presenting with hypoxemic pneumonia — always check SpO₂ and CXR before attributing confusion to "sundowning."

Atelectasis presentation (typically POD 1–2):

Postoperative pneumonia presentation (typically POD 3–7):

Key history elements to anchor on:

Ask about adherence to incentive spirometry and ambulation orders — non-adherence is a modifiable risk factor often surfaced in CCS-style stems.

Physical Exam Findings and Bedside Assessment

— Splinting, shallow breathing, reluctance to cough (especially upper abdominal incisions)

— Diaphoresis, accessory muscle use, nasal flaring suggest impending respiratory failure

— Mental status changes: agitation (early hypoxia) → lethargy (hypercapnia)

— Tachypnea (RR >20) is the earliest and most sensitive sign of PPC

— SpO₂ trend more important than absolute number — a drop from 98% to 92% on same FiO₂ is meaningful

— Fever pattern (timing matters — see chunk 1)

— Tachycardia disproportionate to fever raises concern for PE or sepsis

— Atelectasis: decreased breath sounds at bases, dullness to percussion, bronchial breath sounds over consolidated segments, end-inspiratory crackles that clear with cough

— Pneumonia: focal crackles, bronchophony, egophony ("E-to-A"), tactile fremitus increased over consolidation, purulent sputum

— Pleural effusion (parapneumonic): dullness, absent fremitus, decreased breath sounds

— Pneumothorax (post-thoracic surgery, CVC placement): hyperresonance, absent breath sounds, tracheal deviation if tension

— JVD and S3 suggest fluid overload mimicking PPC — common in elderly receiving aggressive crystalloid

— Hypotension + hypoxemia + tachycardia = consider PE, sepsis, or tension pneumothorax before atelectasis

— Inspect for wound dehiscence, ileus (distended tympanic abdomen splints diaphragm)

— NG tube position — malposition increases aspiration risk

— Bedside swallow screen before resuming PO in high-risk patients (stroke, prolonged intubation >48 hr)

CCS pearl: On the CCS interface, order continuous pulse oximetry and vital signs q4h in the early postoperative period for any patient with risk factors; examine chest as a recurring action — the simulator rewards reassessment after interventions like incentive spirometry, ambulation, or diuresis.

General appearance:

Vital signs:

Pulmonary exam:

Cardiac/hemodynamic:

Incision and abdomen:

Neurologic/swallow:

Diagnostic Workup — Initial Labs, Imaging, ABG

— Atelectasis: plate-like linear opacities at bases, volume loss, elevated hemidiaphragm, mediastinal shift toward affected side, fissure displacement

— Pneumonia: lobar or segmental consolidation, air bronchograms, no volume loss (vs. atelectasis)

— Parapneumonic effusion: blunted costophrenic angle, layering on lateral decubitus

— Pulmonary edema: bilateral perihilar opacities, Kerley B lines, cephalization, cardiomegaly — a key mimic

Board pearl: A post-op patient with clear lungs on CXR but significant A-a gradient and tachycardia should prompt PE workup with CT pulmonary angiography — atelectasis with hypoxemia usually has visible CXR changes.

Pulse oximetry: first-line, continuous in high-risk patients. SpO₂ <92% on room air or new O₂ requirement triggers further workup.

Chest X-ray (PA/lateral preferred; portable AP if unstable):

CBC with differential: leukocytosis with left shift supports infection; leukopenia is an ominous sepsis sign.

Basic metabolic panel: assess renal function for antibiotic dosing and contrast considerations.

Lactate: elevated lactate (>2 mmol/L) in a post-op patient with hypoxemia raises sepsis vs. PE; >4 mmol/L mandates aggressive resuscitation.

Procalcitonin: can help differentiate bacterial pneumonia from non-infectious causes and guide antibiotic duration (stop when <0.25 ng/mL or 80% drop from peak); not required for initial diagnosis.

Blood cultures × 2 before antibiotics in suspected pneumonia with fever or sepsis criteria.

Sputum Gram stain and culture: obtain in suspected HAP, especially before/within hours of antibiotics; endotracheal aspirate preferred in intubated patients.

ABG: indicated for SpO₂ <90% on supplemental O₂, altered mental status, or suspected hypercapnia (COPD, opioid excess, OSA). A-a gradient elevation supports V/Q mismatch (atelectasis, pneumonia, PE).

ECG and troponin if tachycardia, chest pain, or hemodynamic instability — rule out MI and right heart strain pattern (S1Q3T3) suggesting PE.

Diagnostic Workup — Advanced and Confirmatory Studies

— Increasingly Step 3-relevant; B-lines suggest interstitial edema or pneumonia

— Detects pleural effusion and consolidation rapidly

— Useful in unstable patients who cannot leave the unit

— Therapeutic: clears mucus plugs causing lobar collapse refractory to chest physiotherapy (classic indication: complete lobar atelectasis with persistent hypoxemia)

— Diagnostic: bronchoalveolar lavage (BAL) in immunocompromised, ventilator-associated pneumonia, or failure to improve on empiric antibiotics — quantitative cultures (≥10⁴ CFU/mL for BAL, ≥10³ for protected specimen brush)

Step 3 management: A post-op patient with complete lobar collapse on CXR and worsening hypoxemia despite 24 hours of incentive spirometry, nebulizers, and ambulation should prompt therapeutic bronchoscopy rather than continued conservative measures. Recognize this trigger.

Key distinction: Empyema (purulent pleural fluid, loculated, pH <7.2) demands drainage + antibiotics; uncomplicated parapneumonic effusion responds to antibiotics alone.

CT chest (non-contrast): higher sensitivity for atelectasis, occult pneumonia, abscess, empyema, and underlying nodules; useful when CXR is equivocal or patient is not responding to therapy.

CT pulmonary angiography (CTPA): gold standard for suspected PE; Wells score ≥4 or elevated d-dimer in non-low-pretest probability patients. Post-op patients have inherently elevated d-dimer — interpret with caution; consider going directly to imaging.

Bedside lung ultrasound (POCUS):

Bronchoscopy:

Echocardiogram: if PE confirmed and concern for right heart strain (consider thrombolytics in submassive/massive PE); also evaluates LV function if pulmonary edema is a competing diagnosis.

Thoracentesis: for parapneumonic effusion meeting criteria (pH <7.2, glucose <60, LDH >1000, frank pus, positive Gram stain) — complicated parapneumonic effusion or empyema requires drainage (chest tube ± fibrinolytics, or VATS).

Pulmonary function testing: not acute setting — used preoperatively in select patients (lung resection candidates: FEV1, DLCO, predicted post-op FEV1 >40%).

Risk Stratification and Prevention-First Management Logic

— ARISCAT score: age, preop SpO₂, recent respiratory infection, anemia, surgical incision site, surgery duration, emergency surgery — stratifies low/intermediate/high risk

— Gupta calculator: estimates postoperative respiratory failure and pneumonia risk

— STOP-BANG: OSA screening (≥3 = intermediate, ≥5 = high risk)

— Smoking cessation: ideally ≥8 weeks preoperatively to reduce PPCs; even 4 weeks helps for wound healing

— Pulmonary rehabilitation in COPD candidates undergoing thoracic/upper abdominal surgery

— Treat active infection before elective surgery — delay if active bronchitis, URI within 2–4 weeks (especially children)

— Optimize asthma/COPD: inhaled controllers at baseline; consider preop steroids if uncontrolled

— Nutritional optimization: if albumin <3.0 and elective surgery, consider 7–14 days of supplementation

— Incentive spirometry teaching preoperatively (more effective than postoperative initiation alone)

— Lung-protective ventilation: Vt 6–8 mL/kg ideal body weight, PEEP 5–8, recruitment maneuvers

— Avoid excessive FiO₂ (target 30–40%) to reduce absorption atelectasis

— Minimize neuromuscular blockade duration; ensure full reversal (sugammadex or neostigmine + glycopyrrolate) — residual paralysis is a major preventable cause of postoperative respiratory failure

— Regional anesthesia/neuraxial when feasible reduces PPCs

— Incentive spirometry q1h while awake

— Cough and deep breathing

— Oral care (chlorhexidine) — reduces VAP and HAP

— Understanding (patient education)

— Get out of bed ≥3×/day

— Head of bed elevated ≥30°

Board pearl: The single most evidence-supported intervention to prevent both atelectasis and HAP is early ambulation and head-of-bed elevation, not incentive spirometry alone.

Preoperative risk stratification tools:

Modifiable risk factors (preoperative optimization):

Intraoperative strategies:

Postoperative bundles (the "I COUGH" or ERAS pulmonary bundle):

Pharmacotherapy — Empiric Antibiotic Regimens

Standard HAP, low mortality risk, no MDR risk factors:

— Monotherapy: piperacillin-tazobactam, cefepime, levofloxacin, or imipenem/meropenem

— Must cover MSSA and Pseudomonas

HAP with MDR risk factors (IV antibiotics in past 90 days, septic shock, ARDS, ≥5 days hospitalization before VAP, acute renal replacement therapy, structural lung disease):

— Two anti-pseudomonal agents from different classes PLUS

— MRSA coverage: vancomycin (trough 15–20) or linezolid (preferred if AKI or concomitant nephrotoxins)

— Example combo: piperacillin-tazobactam + tobramycin + vancomycin

— Or: cefepime + ciprofloxacin + linezolid

Step 3 management: Always send sputum/BAL cultures before starting empiric antibiotics, then reassess at 48–72 hours with cultures and clinical trajectory — narrow spectrum, stop if pneumonia ruled out. Antibiotic stewardship is heavily tested.

Board pearl: Procalcitonin <0.25 ng/mL with clinical improvement supports discontinuation by day 5–7.

Hospital-acquired pneumonia (HAP) = pneumonia ≥48 hours after admission, not present at admission. Postoperative pneumonia almost always meets HAP criteria.

Ventilator-associated pneumonia (VAP) = pneumonia ≥48 hours after intubation.

Empiric coverage logic (IDSA/ATS 2016 guidelines):

Duration: 7 days for most HAP/VAP (shortened from older 14-day standard); extend if slow response, immunocompromise, or specific pathogens (Pseudomonas bacteremia, S. aureus bacteremia).

De-escalation: narrow based on culture results within 48–72 hours; stop MRSA coverage if MRSA not isolated; tailor antipseudomonal therapy.

Aspiration pneumonia: Streptococcus, oral anaerobes — community-acquired aspiration → ampicillin-sulbactam or ceftriaxone; healthcare-associated → piperacillin-tazobactam (already covers anaerobes). Clindamycin alternative if penicillin allergy.

Adjunctive bronchodilators: albuterol/ipratropium nebulizers for wheezing or known obstructive disease — symptomatic only.

Mucolytics: N-acetylcysteine and hypertonic saline have limited evidence in routine postoperative atelectasis; not first-line.

Non-Pharmacologic and Procedural Management

— Incentive spirometry q1h while awake — sets sustained maximal inspiration goal; teach preoperatively for maximum benefit

— Deep breathing and directed coughing — "huff cough" technique reduces splinting pain

— Early ambulation — out of bed POD 0–1, walking POD 1; the single highest-yield intervention

— Head of bed ≥30° — reduces aspiration and improves FRC

— Chest physiotherapy / percussion — for patients unable to participate (neuromuscular weakness, pediatric, post-thoracic)

— Positive expiratory pressure (PEP) devices, flutter valves, Acapella — for retained secretions

— Multimodal analgesia: scheduled acetaminophen + NSAIDs (if no contraindication) + opioid PRN

— Regional/neuraxial: thoracic epidural for thoracotomy/upper abdominal surgery — significantly reduces PPCs

— Avoid oversedation — titrate opioids carefully, especially in OSA and elderly

— Nasal cannula → high-flow nasal cannula (HFNC) for moderate hypoxemia — HFNC reduces reintubation in post-extubation respiratory failure

— Noninvasive ventilation (BiPAP/CPAP): indicated for post-op hypoxemic respiratory failure, COPD exacerbation, OSA patients, and cardiogenic pulmonary edema; caution after upper GI anastomoses (risk of disrupting anastomosis with gastric distension) — relative contraindication

CCS pearl: On CCS, for postoperative atelectasis order incentive spirometry, ambulation, chest physiotherapy, adequate analgesia, head of bed 30°, and supplemental O₂ — then reassess in 4–6 hours. Sequential reassessment scores well.

First-line for atelectasis (non-pharmacologic bundle):

Pain control optimization (enables deep breathing):

Oxygen therapy:

Therapeutic bronchoscopy: for lobar collapse with mucus plugging refractory to 24–48 hours of conservative measures.

Mechanical ventilation: indications include PaO₂/FiO₂ <200 despite NIV, hypercapnia with acidosis (pH <7.25), inability to protect airway, hemodynamic instability.

Tube thoracostomy: for complicated parapneumonic effusion, empyema, or pneumothorax.

Special Populations — Elderly and Renal/Hepatic Impairment

— Baseline reductions in FRC, ciliary function, cough strength, and chest wall compliance

— Delirium often masks the typical presentation of pneumonia — confusion may be the only sign

— Higher aspiration risk due to dysphagia, dentition, sedating medications

— Frailty index more predictive than chronologic age — assess gait speed, grip strength

— Avoid Beers list anticholinergics, benzodiazepines, and long-acting opioids

— Pneumococcal vaccination status should be confirmed and updated (PCV20 or PCV15+PPSV23 per CDC)

— Goals-of-care discussion before high-risk surgery — code status, intubation preferences

— Dose adjustments:

— Piperacillin-tazobactam: reduce frequency with CrCl <40

— Cefepime: dose-adjust; high doses → cefepime-induced neurotoxicity (myoclonus, encephalopathy) — especially in elderly with CKD

— Vancomycin: AUC-based dosing (target AUC 400–600), monitor troughs

— Aminoglycosides: nephrotoxic — avoid if alternatives exist; if used, once-daily dosing and trough monitoring

— Linezolid preferred over vancomycin in significant AKI or concomitant nephrotoxins

— Avoid NSAIDs for analgesia in CKD

— Avoid hepatotoxic agents; adjust acetaminophen (max 2 g/day in cirrhosis)

— Levofloxacin and azithromycin generally safe; tigecycline avoided

— Increased risk of hepatic encephalopathy with sedatives and opioids — use lowest effective dose

— Ascites can splint diaphragm → worsen atelectasis; consider therapeutic paracentesis preop

— Broader differential: Pneumocystis, CMV, fungal (Aspergillus), atypical mycobacteria

— Lower threshold for BAL and CT chest

— Coordinate with infectious disease

Board pearl: Cefepime neurotoxicity in elderly with unrecognized CKD is a classic Step 3 stem — presents as new-onset confusion, myoclonus, or non-convulsive status epilepticus days into therapy. Dose-adjust or switch.

Elderly (age ≥65):

Chronic kidney disease / AKI:

Hepatic impairment:

Immunocompromised (transplant, chemotherapy, chronic steroids):

Special Populations — Pregnancy, Pediatrics, and OSA

— Postoperative pulmonary risk increased by reduced FRC (gravid uterus elevates diaphragm), increased oxygen consumption, physiologic respiratory alkalosis

— Aspiration risk markedly elevated — full stomach precautions, RSI for emergent surgery

— Imaging: CXR with abdominal shielding is safe; CTPA acceptable when PE suspicion is high (benefits > minimal fetal radiation risk); V/Q scan alternative

— Safe antibiotics: beta-lactams, macrolides (azithromycin), clindamycin

— Avoid: fluoroquinolones (cartilage concerns), tetracyclines (teeth/bone), aminoglycosides (ototoxicity — only if life-threatening)

— Left lateral decubitus positioning improves preload and oxygenation

— Higher tendency to atelectasis due to compliant chest wall and lower FRC

— Delay elective surgery 2–4 weeks after URI (especially <1 year old) — increased risk of bronchospasm, laryngospasm, hypoxemia

— Active wheezing or recent RSV → postpone unless emergent

— Postoperative care: humidified O₂, careful fluid management (avoid hyponatremia), age-appropriate analgesia

— A heavily tested Step 3 population — STOP-BANG ≥3 or known OSA without CPAP

— Highly susceptible to opioid-induced respiratory depression and rebound hypoxemia during REM sleep on POD 2–3

— Bring home CPAP machine to hospital and use immediately postoperatively

— Continuous pulse oximetry monitoring on the ward

— Multimodal opioid-sparing analgesia, avoid benzodiazepines

— Consider extended PACU stay; ICU if severe OSA + opioid requirement

— Ramped positioning for intubation, reverse Trendelenburg postoperatively

— Higher PEEP requirements; lung-protective ventilation

— VTE prophylaxis dose adjustment

Step 3 management: An OSA patient who arrives without home CPAP and is placed on PCA opioids overnight is a setup for desaturation, code, or death — arrange home CPAP as a discrete order on admission.

Pregnancy:

Pediatrics:

Obstructive sleep apnea (OSA):

Morbid obesity (BMI ≥40):

Complications and Adverse Outcomes

— Hypoxemic (Type I): refractory to supplemental O₂ → escalate to HFNC, NIV, or intubation

— Hypercapnic (Type II): consider opioid excess, OSA, COPD, neuromuscular fatigue

— ARDS in severe pneumonia or aspiration: PaO₂/FiO₂ <300, bilateral infiltrates, not cardiogenic

— Pneumonia is the most common source of postoperative sepsis

— Apply Hour-1 bundle: lactate, blood cultures, broad-spectrum antibiotics within 1 hour, 30 mL/kg crystalloid, vasopressors if MAP <65 after fluid

— Empyema → chest tube drainage ± intrapleural fibrinolytics (tPA + DNase) or VATS

— Lung abscess → prolonged antibiotics (4–6 weeks), drainage rarely needed

— Risks ventilator-associated events, ICU-acquired weakness, delirium

— Increases 30-day mortality 5–10×

— Pneumonitis (Mendelson syndrome): chemical injury, presents within hours, often resolves in 24–48 hours, no antibiotics initially

— Pneumonia: delayed (24–72 hours), persistent fever and infiltrate, requires antibiotics

Key distinction: Aspiration pneumonitis vs pneumonia — withholding antibiotics initially in pneumonitis (treat supportively, antibiotics only if no improvement in 48 hours or initial severe presentation) is a high-yield Step 3 stewardship point.

Progressive respiratory failure:

Sepsis and septic shock:

Empyema and lung abscess:

Pulmonary embolism: competing/coexisting diagnosis — pneumonia inflammation promotes thrombosis; never forget VTE prophylaxis.

Clostridioides difficile colitis: from broad-spectrum antibiotics — fluoroquinolones and clindamycin highest risk; treat with oral vancomycin or fidaxomicin (metronidazole is no longer first-line).

Anastomotic leak (post-GI surgery): can present with sepsis and pulmonary symptoms — don't anchor on pneumonia. Persistent tachycardia, leukocytosis, or rising CRP without clear pulmonary findings → CT with contrast.

Reintubation and prolonged mechanical ventilation:

Tracheal stenosis: late complication of prolonged intubation (>1 week) — presents weeks later with stridor.

Aspiration pneumonitis vs. pneumonia:

When to Escalate Care — ICU, Consults, and Triage

— Septic shock requiring vasopressors

— Respiratory failure requiring mechanical ventilation, NIV, or HFNC >50 L/min FiO₂ >60%

— PaO₂/FiO₂ <250 or PaO₂ <60 on supplemental O₂

— RR >30, accessory muscle use, paradoxical breathing

— Hemodynamic instability, lactate >4

— Altered mental status from hypoxia/hypercapnia

— Two or more IDSA minor criteria for severe CAP (adapted to HAP): multilobar infiltrates, confusion, BUN >20, leukopenia, thrombocytopenia, hypothermia, hypotension requiring fluid resuscitation

— Sustained SpO₂ <90% despite supplemental O₂

— RR >30 or <8

— Sudden mental status change

— SBP <90 unresponsive to small fluid bolus

— Pulmonology: refractory atelectasis requiring bronchoscopy, suspected interstitial process, complex weaning

— Infectious disease: MDR organisms, immunocompromised host, failure to respond to empiric therapy, suspected fungal or atypical pathogen

— Thoracic surgery: empyema requiring VATS, persistent air leak, bronchopleural fistula

— Interventional radiology: loculated effusion drainage, lung abscess drainage if surgical contraindication

— Palliative care: patients with advanced underlying disease, multiple comorbidities, declining trajectory — early integration improves symptom management and reduces non-beneficial ICU use

— Stable on ≤4 L NC, no vasopressors ≥24 hours, afebrile or trending down, normalized lactate

CCS pearl: On CCS, transfer to ICU is a concrete action — order it when the patient meets criteria above. Don't continue ward-level monitoring on a patient with rising O₂ requirement and tachypnea. Document goals-of-care conversation in elderly/frail patients before escalation.

ICU transfer criteria for postoperative pneumonia/respiratory failure:

Rapid response activation:

Consult triggers:

Discharge from ICU back to ward:

Key Differentials — Other Pulmonary Causes of Postoperative Hypoxemia

— Hallmarks: sudden onset hypoxemia, tachycardia disproportionate to fever, pleuritic chest pain, often clear lungs

— Risk peaks POD 5–10 but can occur anytime

— Diagnosis: CTPA (gold standard); V/Q if contrast contraindicated

— Treatment: therapeutic anticoagulation (heparin → DOAC or warfarin); thrombolytics for massive PE

— Bilateral perihilar infiltrates, JVD, S3, elevated BNP, history of CHF or aggressive fluid resuscitation

— Treatment: diuresis, afterload reduction, NIV

— Bilateral infiltrates, PaO₂/FiO₂ <300, PCWP <18 or no LAH evidence

— Causes: sepsis, aspiration, massive transfusion (TRALI), pancreatitis

— Treatment: lung-protective ventilation, prone positioning if severe

— Sudden hypoxemia, decreased breath sounds, hyperresonance

— Post-thoracic, post-CVC placement (especially subclavian), barotrauma

— Treatment: needle decompression if tension, chest tube

— Wheezing, prolonged expiration, response to bronchodilators

— Triggers: beta-blockers, NSAIDs (aspirin-exacerbated respiratory disease), extubation

— Sudden hypoxemia + lobar opacity on CXR; therapeutic bronchoscopy

— Transudative (CHF, hypoalbuminemia) vs exudative (parapneumonic, malignancy); Light's criteria

— Witnessed event or risk factors; right lower lobe most common (segmental anatomy)

— Phrenic nerve injury post-cardiac or neck surgery — paradoxical breathing, elevated hemidiaphragm

Board pearl: In a post-op patient with acute hypoxemia and clear CXR, the top differential is PE until proven otherwise — proceed to CTPA without delaying for d-dimer in moderate-high pretest probability.

Pulmonary embolism (PE):

Pulmonary edema (cardiogenic):

ARDS (non-cardiogenic):

Pneumothorax:

Bronchospasm/asthma exacerbation:

Mucus plugging causing lobar collapse:

Pleural effusion:

Aspiration:

Diaphragmatic dysfunction:

Key Differentials — Non-Pulmonary Causes of Postoperative Fever/Tachypnea

— Wind (POD 1–2): atelectasis, pneumonia (later)

— Water (POD 3–5): UTI, especially with indwelling catheters

— Walking/Wound (POD 5–7): DVT/PE, surgical site infection

— Wonder drugs (anytime): drug fever, transfusion reactions

— What did we do? (anytime): line infections, abscess, anastomotic leak

— Superficial: erythema, drainage, induration around incision

— Deep/organ-space: fever, abdominal pain, ileus — CT to evaluate

— Risk rises with each day of Foley use; remove catheters as early as possible — a core patient safety measure

— Dysuria masked in catheterized patients; suspect with fever, flank pain, altered mental status

— Persistent fever, no clear source, positive blood cultures with skin flora (CoNS, S. aureus)

— Remove line, culture catheter tip

— Diarrhea, leukocytosis (often markedly elevated >15,000), low-grade fever, recent antibiotic exposure

— Stool PCR or GDH + toxin EIA

— Beta-lactams, sulfonamides, anticonvulsants; eosinophilia and rash may be present

— Resolves within 72 hours of discontinuation

— TRALI within 6 hours of transfusion; TACO with volume overload

— Febrile non-hemolytic, hemolytic reactions

— Patients on chronic steroids who didn't receive stress-dose coverage — hypotension, hyponatremia, hypoglycemia

Key distinction: Postoperative fever in the first 48 hours that's accompanied by diarrhea and marked leukocytosis raises C. difficile over atelectasis — anchoring bias is heavily tested.

The classic "5 W's" of postoperative fever:

Surgical site infection (SSI):

Urinary tract infection (CAUTI):

Central line-associated bloodstream infection (CLABSI):

C. difficile colitis:

Drug fever:

Transfusion reactions:

Adrenal insufficiency:

Thyroid storm, malignant hyperthermia, neuroleptic malignant syndrome: rare but classic.

Secondary Prevention and Discharge Planning

— Most HAP treated 7 days; complete oral step-down at home if clinically stable, afebrile 48 hours, tolerating PO, and stable oxygenation

— Common step-down options: levofloxacin, amoxicillin-clavulanate, doxycycline (pathogen-directed)

— Educate on adherence, side effects, and C. difficile warning signs (diarrhea → call clinician, don't take antidiarrheals)

— Postoperative period is a powerful "teachable moment" — quit rates double when intervention starts in hospital

— Offer varenicline, bupropion, or nicotine replacement therapy + behavioral counseling and quitline referral

— Influenza vaccine seasonally

— Pneumococcal (PCV20 alone, or PCV15 followed by PPSV23) for age ≥65 or high-risk comorbidities

— COVID-19 per current CDC recommendations

— Tdap if not current

— Confirm correct technique with bedside demonstration (a measurable hospital quality metric)

— Long-acting maintenance therapy at discharge; rescue inhaler available

— High-risk patients (cancer surgery, hip/knee arthroplasty) may need extended prophylaxis (28–35 days)

— Order resting and ambulatory pulse oximetry before discharge if any concern; qualifying criteria: PaO₂ ≤55 or SpO₂ ≤88% at rest, with exertion, or during sleep

— Refer for outpatient polysomnography if STOP-BANG ≥5 and not previously diagnosed; ensure CPAP adherence in known OSA

— COPD patients with recent hospitalization show mortality benefit and reduced readmissions

Step 3 management: A patient discharged after postoperative pneumonia with a new oxygen requirement needs outpatient pulmonary follow-up within 1–2 weeks, repeat imaging in 6–8 weeks to confirm resolution, and reassessment for home oxygen necessity — non-resolving infiltrates raise concern for post-obstructive pneumonia from malignancy (especially smokers >50).

Antibiotic course completion:

Smoking cessation:

Vaccinations before discharge:

Inhaler optimization for COPD/asthma patients:

VTE prophylaxis continuation:

Home oxygen evaluation:

OSA evaluation:

Pulmonary rehabilitation referral:

Follow-Up, Monitoring, and Rehab/Counseling

— Primary care or surgeon visit within 7–14 days of discharge

— Repeat chest X-ray at 6–8 weeks to confirm radiographic resolution (especially in smokers ≥50 years old — a non-resolving infiltrate may be obstructing tumor)

— Pulmonology follow-up within 2–4 weeks for patients with new oxygen requirements, severe disease, or underlying chronic lung disease

— Pulse oximetry if discharged on oxygen — target SpO₂ ≥90% (88–92% in COPD)

— Symptom diary: cough, sputum production, dyspnea on exertion, fever

— Weight (for CHF overlap), exercise tolerance, return to baseline activity

— New or worsening dyspnea, chest pain, hemoptysis

— Persistent fever >48 hours despite completing antibiotics

— Productive cough with new purulent sputum

— Calf swelling/pain (DVT)

— Confusion, lightheadedness

— Structured 6–12 week program: exercise training, education, breathing techniques, nutrition, psychosocial support

— Strongest evidence in COPD; benefits also in post-thoracic surgery, interstitial lung disease, pre-lung transplant

— Smoking cessation reinforcement at every visit (5 A's: Ask, Advise, Assess, Assist, Arrange)

— Vaccination updates

— Inhaler technique reassessment

— Aspiration precautions for high-risk patients (head of bed elevation, modified diet, swallow therapy)

— Activity progression: gradual return to baseline; supervised exercise testing in select patients

— Post-ICU syndrome and PTSD in patients with prolonged respiratory failure — screen at follow-up

— Depression and anxiety increase readmission rates

Board pearl: A non-resolving infiltrate at 6–8 weeks in a smoker ≥50 years old should prompt CT chest with contrast to evaluate for underlying malignancy causing post-obstructive pneumonia — this is a frequently tested Step 3 diagnostic pivot, and missing it is a malpractice trap.

Follow-up cadence:

Monitoring parameters at home:

Red-flag symptoms requiring urgent contact:

Pulmonary rehabilitation:

Counseling priorities:

Mental health:

Ethical, Legal, and Patient Safety Considerations

— Patients have the right to refuse incentive spirometry, ambulation, NIV, or CPAP — document refusal, explain risks (pneumonia, reintubation, prolonged stay), reassess daily, involve family

— Capacity assessment: delirious or hypoxic patients may lack capacity; engage surrogate decision-maker per state hierarchy

— Elderly or frail patients with pneumonia and rising O₂ requirement → proactively revisit code status before crisis (intubation vs. comfort-focused care, NIV trial with time-limited goals)

— Time-limited trials (e.g., "72-hour trial of NIV; reassess") are ethically sound and improve family decision-making

— VAP prevention bundle: head of bed 30–45°, daily sedation interruption, daily spontaneous breathing trials, oral chlorhexidine, DVT/PUD prophylaxis, subglottic suctioning

— CAUTI prevention: remove Foley catheters as early as possible (a never-event metric)

— CLABSI prevention: chlorhexidine skin prep, full barrier precautions, daily line necessity review

— Hand hygiene and isolation precautions for MDR organisms

— Medication reconciliation at discharge — incomplete antibiotic courses, missed inhalers, omitted VTE prophylaxis are common errors

— Ensure follow-up appointment is scheduled before discharge; provide written instructions in patient's preferred language and health literacy level

— Teach-back method to verify understanding of red-flag symptoms and medication plan

— Hospital-acquired infections (HAP, CLABSI, CAUTI) are reportable to NHSN and CMS; affect reimbursement and public quality scores

— Suspected elder abuse if functional decline or neglect contributes to aspiration pneumonia presentation

— If a preventable PPC results from missed CPAP order, unrecognized aspiration, or delayed antibiotic — full, prompt disclosure to patient/family is ethically and legally required

Step 3 management: A frail 84-year-old with HAP and rising vasopressor requirement — convene a family meeting within 24–48 hours with palliative care to align treatment with goals.

Informed consent for preventive measures:

Goals-of-care and advance directives:

Patient safety bundles and quality measures:

Transition-of-care risks (Step 3 favorite):

Mandatory reporting:

Disclosure of medical error:

High-Yield Associations and Rapid-Fire Clinical Facts

Board pearl: Memorize the "5 W's" of postoperative fever timing — it remains one of the most directly tested frameworks across Step 2 and Step 3.

Most common cause of fever POD 1–2: atelectasis (controversial — newer evidence suggests inflammatory cytokines, not atelectasis itself, drive early fever) — but classic Step 3 answer remains atelectasis.

Most common postoperative pulmonary complication: atelectasis.

Most common organism in HAP: Staphylococcus aureus (including MRSA), followed by Pseudomonas aeruginosa, Klebsiella, Enterobacter.

Highest-risk surgery for PPC: thoracic and upper abdominal (especially esophagectomy, AAA repair).

Single best preoperative modifiable factor: smoking cessation ≥8 weeks before surgery.

Single best postoperative intervention: early ambulation and head-of-bed elevation.

Best analgesia to reduce PPCs in thoracic/upper abdominal surgery: thoracic epidural.

Aspiration pneumonia most common location: right lower lobe (upright) or right upper lobe posterior segment (supine).

Lobar collapse with mediastinal shift TOWARD the opacity: atelectasis (volume loss).

Lobar consolidation with mediastinal shift AWAY: mass, large effusion, or pneumothorax.

Mendelson syndrome: chemical pneumonitis from gastric acid aspiration — supportive care, no initial antibiotics.

Cefepime neurotoxicity: myoclonus and encephalopathy in renal impairment.

C. diff first-line: oral vancomycin or fidaxomicin (not metronidazole).

Procalcitonin <0.25 ng/mL: supports stopping antibiotics.

VAP bundle components: HOB ≥30°, daily sedation interruption, SBT, oral chlorhexidine, DVT/PUD prophylaxis.

CURB-65 / PSI: community-acquired pneumonia severity scores (less applicable in HAP, but conceptually similar minor criteria for ICU admission).

Fat embolism triad: hypoxemia + petechiae + neurologic changes 24–72 hours after long-bone fracture.

Post-thoracic surgery diaphragm paralysis: phrenic nerve injury → elevated hemidiaphragm, dyspnea.

Empyema treatment: chest tube drainage + antibiotics ± fibrinolytics or VATS.

Board Question Stem Patterns

— Setup: 65 yo s/p upper abdominal surgery, T 38.1, SpO₂ 94% RA, basilar crackles, splinting cough

— Best answer: incentive spirometry, ambulation, pain control — NOT antibiotics, NOT CXR-first

— Setup: 72 yo s/p hip fracture repair, T 39.0, purulent sputum, RLL consolidation, WBC 16

— Best answer: blood and sputum cultures, then empiric piperacillin-tazobactam + vancomycin (HAP with MDR risk: hospitalization >2 days, age, recent abx)

— Setup: POD 3, complete left lower lobe collapse on CXR, hypoxemic despite 48 hours of IS and ambulation

— Best answer: therapeutic bronchoscopy

— Setup: sudden dyspnea, tachycardia, calf swelling, CXR unremarkable

— Best answer: CT pulmonary angiography — don't bother with d-dimer

— Setup: BMI 42, STOP-BANG 6, on morphine PCA, now SpO₂ 84%, somnolent

— Best answer: stop PCA, naloxone if severe, initiate CPAP, multimodal opioid-sparing analgesia

— Setup: witnessed emesis with cough during induction, transient hypoxemia, infiltrate develops, afebrile, improving

— Best answer: supportive care, NO antibiotics initially (pneumonitis, not pneumonia)

— Setup: 60 yo smoker, treated HAP, post-treatment CXR shows persistent RUL opacity

— Best answer: CT chest with contrast to evaluate for malignancy

— Setup: POD 5, on cefepime for HAP, new myoclonus and altered sensorium

— Best answer: stop cefepime, suspect cefepime neurotoxicity, consider EEG

Step 3 management: Notice that Step 3 stems consistently reward measured initial intervention (preventive bundle), escalation timing, and avoiding antibiotic overuse.

Pattern 1 — POD 1 low-grade fever and basilar crackles:

Pattern 2 — POD 4 high fever with productive cough and infiltrate:

Pattern 3 — Lobar collapse refractory to therapy:

Pattern 4 — Acute hypoxemia with clear CXR POD 5–7:

Pattern 5 — OSA patient with PCA opioids and desaturation:

Pattern 6 — Aspiration event without infection:

Pattern 7 — Smoker with non-resolving infiltrate at 8 weeks:

Pattern 8 — New confusion in elderly with CKD on cefepime:

One-Line Recap

Postoperative atelectasis and pneumonia prevention hinges on identifying high-risk patients preoperatively, optimizing modifiable risks, executing a structured early-mobilization and lung-expansion bundle, and reserving empiric HAP antibiotics with cultures and stewardship for confirmed infection — not for early fever.

Board pearl: The Step 3 examiner rewards the clinician who prevents PPCs through bundles and stewards antibiotics carefully — early fever is rarely pneumonia, and treating it as such is the wrong answer more often than the right one. Master the preventive bundle, the timing of postoperative fever, and the escalation triggers (refractory hypoxemia, lobar collapse, septic shock) and you will navigate this entire topic confidently across CCS cases and MCQ stems alike.

Prevent first: smoking cessation ≥8 weeks preop, pulmonary optimization, lung-protective ventilation, neuromuscular blockade reversal, regional anesthesia when feasible, and the I COUGH/ERAS bundle (incentive spirometry, oral care, head-of-bed elevation, early ambulation).

Diagnose precisely: distinguish atelectasis (POD 1–2, low fever, volume loss on CXR) from HAP (POD 3+, purulent sputum, consolidation, leukocytosis) — and always consider PE in acute hypoxemia with clear CXR; obtain cultures before antibiotics.

Treat appropriately: atelectasis → non-pharmacologic bundle + pain control + bronchoscopy for refractory lobar collapse; HAP → empiric anti-pseudomonal + MRSA coverage with MDR risk factors, 7-day course, de-escalate by 48–72 hours based on cultures and procalcitonin.

Plan the transition: ensure smoking cessation pharmacotherapy, vaccinations, CPAP for OSA, follow-up imaging at 6–8 weeks for non-resolving infiltrates (especially smokers ≥50 — rule out malignancy), pulmonary rehab referral, and goals-of-care alignment in frail/elderly patients.